• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2013 Fiscal Year Annual Research Report

ヒト女性乳癌における男性ホルモン、アンドロゲンの局所産生と作用機序の解明

Research Project

Project/Area Number 11F01735
Research InstitutionTohoku University

Principal Investigator

MCNAMARA Keely  東北大学, 大学院医学系研究科, 助教

KeywordsAndrogen / Breast Cancer / Steroid receptors
Research Abstract

Results of the research above revealed that AR expression in TNBC specimens correlated with lower levels of proliferation and this association was stronger in samples that also expressed enzymes for androgen synthetic pathways. This result was actually contrary to our original hypothesis, based on the research reports from others that groups characterized by very high levels of androgen receptor in the absence of estrogen receptor had a worse prognosis, and is contrary to the results of the dominate group in this area of research. The novelty of this finding was recognized by the research being awarded a prize in the presidential poster competition at the international scientific meeting ENDO2012, lead to an invitation to speak at the 15^<th> International congress on hormonal steroid and hormones & cancer in Kanazawa in 2012 and was subsequently published in the journal cancer science. Since this original contradictory finding we have been searching through possible explanations that reconcile an overall trend showing the pathological analysis reveals the androgen receptor to be a potential suppressor of proliferation, yet cell line and molecular analysis suggesting the androgen receptor as a potential oncogene. Recent data, currently under consideration for publication in the journal breast cancer research and treatment suggests that in triple negative breast cancer there may be at least two distinct types of AR expressing TNBC. In tandem with two recent reports from other groups this may provide important information in patient selection when choosing AR targeting agents as a therapy in TNBC. In addition to this, recent papers suggesting a role of ERβ in breast cancer, combined with the known overlap between androgen receptor and ERβ receptor ligands has led to an expansion of the project to investigate these factors in TNBC.

Strategy for Future Research Activity

(抄録なし)

  • Research Products

    (6 results)

All 2014 2013

All Journal Article (2 results) (of which Peer Reviewed: 2 results) Presentation (4 results)

  • [Journal Article] Androgenic pathways in the progression of triple-negative breast carcinoma : a comparison between aggressive and non-aggressive subtypes2014

    • Author(s)
      McNamara, et al
    • Journal Title

      Breast Cancer Res Treat.

      Pages: accepted

    • DOI

      10.1007/s10549-014-2942-6

    • Peer Reviewed
  • [Journal Article] Phase Two Steroid Metabolism and Its Roles in Breast and Prostate Cancer Patients.2013

    • Author(s)
      McNamara, et al
    • Journal Title

      Front Endocrinol (Lausanne)

      Volume: 4 ; 4 : 116. Pages: 1-7

    • DOI

      10.3389/fendo.2013.00116

    • Peer Reviewed
  • [Presentation] Estrogenic pathways exist in TNBC and correlate with androgen receptor status2013

    • Author(s)
      McNamara, et al
    • Organizer
      San Antonio Breast Cancer Symposium 2013
    • Place of Presentation
      San Antonio アメリカ
    • Year and Date
      20131209-13
  • [Presentation] Clinicopathological significance of Androgen Receptor status in recurrent triple negative breast carcinoma patients2013

    • Author(s)
      McNamara, et al
    • Organizer
      Japanese Cancer Association
    • Place of Presentation
      Yokohama
    • Year and Date
      20131003-05
  • [Presentation] Lack of AR is associated with an increase in Ki-67 labelling index in triple negative ductal carcinoma in situ.2013

    • Author(s)
      McNamara, et al
    • Organizer
      Endocrine Society of Australia
    • Place of Presentation
      Sydney オーストラリア
    • Year and Date
      20130825-28
  • [Presentation] A comparison of an androgenic pathway between development and reoccurrence/progression of triple negative breast cancer patients2013

    • Author(s)
      McNamara, et al
    • Organizer
      ENDO2013
    • Place of Presentation
      San Francisco アメリカ
    • Year and Date
      20130615-18

URL: 

Published: 2015-06-25  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi